美国RayBiotech
RayBiotech,Inc. 目前正致力于为后基因时代开发创新，可靠的技术，在完成人类基因组序列之后，研究人员已经能够分析表达无数与疾病有关的基因。并且他们已经率先开发出高品质的抗体和能够同时有效地分析数百种有关炎症，血管生成，细胞凋亡，细胞生长和从一个单一的生物样品信号转导的蛋白表达结果的蛋白质阵列技术。
产品简介如下：
Cytokine Antibody Array
Quantitative Antibody Array
Apoptosis Array
Phosphorylation Antibody Array
Enzyme Immunoassay (EIA) Based Kits
Protein Array
RayBio® ELISA kit
L Series: Label-Based Antibody Array
Tissue Microarray
Phosphorylation ELISA kit
Peptide & Peptide Synthesis

At RayBiotech, we are committed to developing innovative and reliable technologies for the post-genomic age. Our mission is to provide cutting edge proteomics tools for the advancement of basic and clinical research, the development of better patient diagnostics, and the facilitation of drug and biomarker discovery. It is also our mission to provide excellent service and support to our valued customers.

Following the completion of the human genome sequence, researchers have been able to analyze the expression of a myriad of disease-related genes. However, since many diseases result from abnormal protein expression, post-translational modifications, or interactions with other biomolecules, an understanding of disease states cannot be obtained from genomic research alone. It is our realization that high-throughput and efficient protein analysis offers the most promising approach for discovering novel drug targets, disease biomarkers and therapeutic agents.

At RayBiotech, we have pioneered the development of high quality antibody and protein array technology to efficiently analyze the concurrent expression and function of hundreds of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction from a single biological sample. Thus, RayBiotech provides a reliable high-throughput technology for screening of novel biomarkers, identification of new drug targets, determination of key factors, as well as for accurate, early detection of diseases. Our technologies have the potential to contribute significantly to the realization of the heralded promise of personalized medicine for patients.